Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

INVITED REVIEW

Breast cancer radiotherapy and cardiac risk: The 15-year paradox!

Munshi Anusheel

Year : 2007| Volume: 3| Issue : 4 | Page no: 190-192

   This article has been cited by
 
1 Cardioprotective radiotherapy: The circadian way
Deepak Gupta, Pragya Shukla, Anusheel Munshi, Jai Prakash Aggarwal
Medical Hypotheses. 2012;
[HTML Full text]  [Google Scholar] [DOI]
2 Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model
Heravi, M. and Tomic, N. and Liang, L. and Devic, S. and Holmes, J. and Deblois, F. and Radzioch, D. and Muanza, T.
Anti-Cancer Drugs. 2012; 23(5): 525-533
[Pubmed]  [Google Scholar]
3 Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model
Mitra Heravi,Nada Tomic,LiHeng Liang,Slobodan Devic,Joseph Holmes,François Deblois,Danuta Radzioch,Thierry Muanza
Anti-Cancer Drugs. 2012; 23(5): 525
[Pubmed]  [Google Scholar] [DOI]
4 Multidisciplinary care in oncology: Are we united?
Anusheel Munshi, Manju Sengar
Acta Oncologica. 2011; 50(2): 314
[HTML Full text]  [Google Scholar] [DOI]
5 Breast cancer radiotherapy and cardiac risk
Anusheel Munshi, Kaustav Talapatra, Debanarayan Dutta
Oncology Reviews. 2010; 4(3): 137
[HTML Full text]  [Google Scholar] [DOI]
6 From bench to bedside: The growing use of translational research in cancer medicine
Goldblatt, E.M. and Lee, W.-H.
American Journal of Translational Research. 2010; 2(1): 1-18
[Pubmed]  [Google Scholar]
7 Resource-sparing and cost-effective strategies in current management of breast cancer
Munshi, A.
Journal of Cancer Research and Therapeutics. 2009; 5(2): 116-120
[Pubmed]  [Google Scholar]

 

Read this article